Additionally, we demonstrate that AZD1222 vaccination produces a robust recall NELF IgG response upon breakthrough infection that correlates with reduced viral loads and, alongside NELF IgA, a reduced duration of viral shedding in vaccinees compared with placebo. Here, CD79A is linked to infection.